Skip to main content
Home

Main navigation

  • About Ipnet
    • What is Ipnet ?
    • Statutes & bylaws
    • Membership application
    • Expert Clinical Center application
    • Ipnet Executive Board
    • General Assemblies
    • Ipnet Working Groups
    • Porphyria centres
    • Patient organizations
    • Corporate members
    • Honorary members
  • Patients
    • Introduction to porphyria
    • GPAC information statement
    • Acute porphyria
    • Drugs and acute hepatic porphyrias
    • Acute porphyria - diagnosis - FAQ
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic Protoporphyrias (EPP & XLP)
    • Congenital erythropoietic porphyria (CEP)
    • Skin Protection in Cutaneous Porphyria
    • Patient organizations
    • Porphyria centres
  • Professionals
    • The porphyrias
    • Laboratory diagnosis
    • Investigating the family
    • Treatment of the acute attack
    • Drugs and acute hepatic porphyrias
    • Acute porphyria: how to refer a patient
    • Porphyria Cutanea Tarda (PCT)
    • Erythropoietic protoporphyria (EPP & XLEPP)
    • Webinars
    • Porphyria centres
  • News
  • Research
  • Contact

Ipnet Working Groups

1. Laboratory Working Group (WG-LA)
2. Clinical Working Groups
- 2i. WG2a: Cutaneous porphyrias (WG-CP)
- 2ii. WG2b: Acute porphyrias (WG-AHP)
3. Porphyria Expert Clinical Centers Working Group (WG-PECC)
4. Webpage Working Group (WG-WP)
5. Acute Porphyria International Support Working Group (WG-APIS)
6. Safety of Drugs for Porphyria Patients Working Group (WG-DRUGS)
7. Gene Variant Classification Working Group (WG-GVC)

Home | Disclaimer | GDPR